Puberty Suppressants Trial Debate
Full Debate: Read Full DebateSarah Pochin
Main Page: Sarah Pochin (Reform UK - Runcorn and Helsby)Department Debates - View all Sarah Pochin's debates with the Department of Health and Social Care
(1 day, 20 hours ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
When it was published—I was in the Chamber at the time—there was an overwhelming consensus in the House. There were some people who criticised and challenged the Cass review at the time, including some outside the House in the LGBT community. I have always supported the Cass review, which was led by one of our country’s best paediatricians. Because of that, I am proceeding in the way that I am, which is the way that Dr Cass—now Baroness Cass—recommended. I will continue to follow the evidence and implement the Cass review comprehensively.
Sarah Pochin (Runcorn and Helsby) (Reform)
A survey published today by Transgender Trend shows overwhelming public support for non-intrusive medical approaches for under-16s with gender dysmorphia. The public want this state-sponsored child abuse stopped, so will the Secretary of State represent the will of the people, stop the trial and instead introduce statutory legislation to access the evidence data from the 2,000 children and young people already given puberty blockers through the Tavistock scandal?
I will take the hon. Member’s question in three parts. First, the opinion polling that she mentions shows that people in this country are overwhelmingly kind, and they want to ensure that trans people, and LGBT people more broadly, are treated with kindness, compassion and inclusion. Secondly, I do not dismiss the opinion polling that shows that a majority are against this kind of trial. Thirdly, the reason I am doing this is that I have to think about this extremely small group of people. I do not know what it is like to walk in their shoes and I have to think very carefully about what is in their best interests. The best way to do that is to build the evidence base that we need to provide high-quality healthcare. I strongly, strongly do not agree with her characterisation of this study, which is in itself irresponsible.